BLLN - BillionToOne, Inc.

69.55
-1.890   -2.717%

Share volume: 302,501
Last Updated: 03-27-2026
Healthcare/Services – Health: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$71.44
-1.89
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
65%
Profitability 68%
Dept financing 43%
Liquidity 75%
Performance 65%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-12.61%
1 Month
-11.57%
3 Months
-17.70%
6 Months
-36.16%
1 Year
-36.16%
2 Year
-36.16%
Key data
Stock price
$69.55
P/E Ratio 
0.00
DAY RANGE
$67.70 - $72.34
EPS 
$0.14
52 WEEK RANGE
$61.96 - $138.70
52 WEEK CHANGE
-$36.16
MARKET CAP 
273.066 M
YIELD 
N/A
SHARES OUTSTANDING 
45.769 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$251,658
AVERAGE 30 VOLUME 
$335,569
Company detail
CEO: Oguzhan Atay
Region: US
Website: www.billiontoone.com
Employees: 620
IPO year: 2025
Issue type:
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

BillionToOne is transforming healthcare by redefining molecular diagnostics. Our revolutionary single molecule NGS (smNGS) platform achieves what was once thought impossible – detecting and precisely quantifying genetic targets with single-molecule sensitivity. At the heart of this technological breakthrough lies our patented QCTs, enabling measurements at the physical limit of detection – the single DNA molecule. Our principal executive offices are located in Menlo Park, CA.

Recent news